Malaysian Genomics Resource Centre Berhad reported earnings results for the fourth quarter and full year ended June 30, 2023. For the fourth quarter, the company reported sales was MYR 2.23 million compared to MYR 6.33 million a year ago. Net loss was MYR 11.03 million compared to net income of MYR 4 million a year ago. Basic loss per share from continuing operations was MYR 0.0847 compared to basic earnings per share from continuing operations of MYR 0.0325 a year ago.
For the full year, sales was MYR 8.36 million compared to MYR 28.36 million a year ago. Net loss was MYR 14.25 million compared to net income of MYR 7.21 million a year ago. Basic loss per share from continuing operations was MYR 0.1117 compared to basic earnings per share from continuing operations of MYR 0.0586 a year ago.